These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 27485514)

  • 1. A rational two-step approach to KRAS mutation testing in colorectal cancer using high resolution melting analysis and pyrosequencing.
    Mack E; Stabla K; Riera-Knorrenschild J; Moll R; Neubauer A; Brendel C
    BMC Cancer; 2016 Aug; 16():585. PubMed ID: 27485514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KRAS gene mutation in a series of unselected colorectal carcinoma patients with prognostic morphological correlations: a pyrosequencing method improved by nested PCR.
    de Macêdo MP; de Melo FM; Lisboa BC; Andrade LD; de Souza Begnami MD; Junior SA; Ribeiro HS; Soares FA; Carraro DM; da Cunha IW
    Exp Mol Pathol; 2015 Jun; 98(3):563-7. PubMed ID: 25835782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA.
    Heideman DA; Lurkin I; Doeleman M; Smit EF; Verheul HM; Meijer GA; Snijders PJ; Thunnissen E; Zwarthoff EC
    J Mol Diagn; 2012; 14(3):247-55. PubMed ID: 22425762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of pyrosequencing and QMC-PCR in conjunction with high resolution melting for KRAS/BRAF mutation detection.
    Ibrahem S; Seth R; O'Sullivan B; Fadhil W; Taniere P; Ilyas M
    Int J Exp Pathol; 2010 Dec; 91(6):500-5. PubMed ID: 21199003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KRAS analysis in colorectal carcinoma: analytical aspects of Pyrosequencing and allele-specific PCR in clinical practice.
    Sundström M; Edlund K; Lindell M; Glimelius B; Birgisson H; Micke P; Botling J
    BMC Cancer; 2010 Dec; 10():660. PubMed ID: 21122130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer.
    Vaughn CP; Zobell SD; Furtado LV; Baker CL; Samowitz WS
    Genes Chromosomes Cancer; 2011 May; 50(5):307-12. PubMed ID: 21305640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QIAGEN Therascreen KRAS RGQ Assay, QIAGEN KRAS Pyro Assay, and Dideoxy Sequencing for Clinical Laboratory Analysis of KRAS Mutations in Tumor Specimens.
    Alqahtani QM; Crowley A; Rapp S; Cushman-Vokoun AM
    Lab Med; 2016 Feb; 47(1):30-8. PubMed ID: 26732779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Companion-diagnostic testing limited to KRAS codons 12 and 13 misses 17% of potentially relevant RAS mutations in colorectal cancer.
    Netzel BC; Grebe SK
    Clin Chim Acta; 2013 Oct; 425():1-2. PubMed ID: 23832066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Evaluation of IntelliPlex™ KRAS G12/13 Mutation Kit for Detection of KRAS Mutations in Codon 12 and 13: A Novel Multiplex Approach.
    Chen CL; Chen CK; Ho CL; Chi WM; Yeh CH; Hu SP; Friebe P; Palmer S; Huang CS
    Mol Diagn Ther; 2019 Oct; 23(5):645-656. PubMed ID: 31347028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitive High-Resolution Melting Analysis for Screening of KRAS and BRAF Mutations in Iranian Human Metastatic Colorectal Cancers.
    Karbalaie Niya MH; Basi A; Koochak A; Safarnezhad Tameshkel F; Rakhshani N; Zamani F; Imanzade F; Rezvani H; Adib Sereshki MM; Sohrabi MR
    Asian Pac J Cancer Prev; 2016 Dec; 17(12):5147-5152. PubMed ID: 28122448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KRAS mutation testing in colorectal cancer: comparison of the results obtained using 3 different methods for the analysis of codons G12 and G13.
    Bihl MP; Hoeller S; Andreozzi MC; Foerster A; Rufle A; Tornillo L; Terracciano L
    Diagn Mol Pathol; 2012 Mar; 21(1):14-23. PubMed ID: 22306671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concordance in KRAS and BRAF mutations in endoscopic biopsy samples and resection specimens of colorectal adenocarcinoma.
    Krol LC; 't Hart NA; Methorst N; Knol AJ; Prinsen C; Boers JE
    Eur J Cancer; 2012 May; 48(7):1108-15. PubMed ID: 22446020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of Direct sequencing, Pyrosequencing, High resolution melting analysis, TheraScreen DxS, and the K-ras StripAssay for detecting KRAS mutations in non small cell lung carcinomas.
    Jancik S; Drabek J; Berkovcova J; Xu YZ; Stankova M; Klein J; Kolek V; Skarda J; Tichy T; Grygarkova I; Radzioch D; Hajduch M
    J Exp Clin Cancer Res; 2012 Sep; 31(1):79. PubMed ID: 22995035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KRAS mutation detection in Tunisian sporadic coloractal cancer patients with direct sequencing, high resolution melting and denaturating high performance liquid chromatography.
    Karim B; Florence C; Kamel R; Nadia K; Ines O; Raja M; Sarra BJ; Florent S; Amel BA
    Cancer Biomark; 2010-2011; 8(6):331-40. PubMed ID: 22072121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges posed to pathologists in the detection of KRAS mutations in colorectal cancers.
    Dudley J; Tseng LH; Rooper L; Harris M; Haley L; Chen G; Gocke CD; Eshleman JR; Lin MT
    Arch Pathol Lab Med; 2015 Feb; 139(2):211-8. PubMed ID: 25611103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer.
    Neumann J; Zeindl-Eberhart E; Kirchner T; Jung A
    Pathol Res Pract; 2009; 205(12):858-62. PubMed ID: 19679400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of COBAS 4800 KRAS, TaqMan PCR and high resolution melting PCR assays for the detection of KRAS somatic mutations in formalin-fixed paraffin embedded colorectal carcinomas.
    Harlé A; Busser B; Rouyer M; Harter V; Genin P; Leroux A; Merlin JL
    Virchows Arch; 2013 Mar; 462(3):329-35. PubMed ID: 23400679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two different screening methods for the KRAS mutation in colorectal cancer.
    Er TK; Chang YS; Yeh KT; Chang TJ; Chang JG
    Clin Lab; 2010; 56(5-6):175-86. PubMed ID: 20575464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitive amplification of differentially melting amplicons (CADMA) improves KRAS hotspot mutation testing in colorectal cancer.
    Kristensen LS; Kjeldsen TE; Hager H; Hansen LL
    BMC Cancer; 2012 Nov; 12():548. PubMed ID: 23173730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of routine KRAS mutation PCR-based testing procedure for rational individualized first-line-targeted therapy selection in metastatic colorectal cancer.
    Chretien AS; Harlé A; Meyer-Lefebvre M; Rouyer M; Husson M; Ramacci C; Harter V; Genin P; Leroux A; Merlin JL
    Cancer Med; 2013 Feb; 2(1):11-20. PubMed ID: 24133623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.